Clinical Trials in Philadelphia

Showing 6181-6200 of 20,904 trials

PArtial REbreathing for Migraine With Aura 1

NCT05546385

A prospective, multi-centre, randomized, double-blind, sham-controlled, parallel-group, group-sequential study to investigate safety and effectiveness of the Rehaler partial rebreathing device, in adults suffering from migraine with aura

Migraine With Aura

Rehaler142 participantsStarted Aug 2023

Palo Alto, California, United States • Pasadena, California, United States • Riverside, California, United States +12 more locations

COMPLETEDNA< 1 mile

Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

NCT03241459

To demonstrate the safety and efficacy of the SurVeil Drug-Coated Balloon (DCB) for treatment of subjects with symptomatic peripheral artery disease (PAD) due to stenosis of the femoral and/or popliteal arteries.

Peripheral Arterial DiseasePeripheral Vascular DiseaseArtery Disease, Peripheral+1 more

SurModics, Inc.446 participantsStarted Oct 2017

Birmingham, Alabama, United States • Foley, Alabama, United States • Gilbert, Arizona, United States +60 more locations

PArtial REbreathing for Migraine With Aura 1

Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

Find Trials by Condition in Philadelphia

A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799)

Effects of Ketone Supplementation on Acute Alcohol Withdrawal

A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis

Heart Failure Optimization Study

ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D

SUBLOCADE Rapid Initiation Study

SUBLOCADE Rapid Initiation Extension Study

Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)

PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors

Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma

A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

A Prospective Observational Study of TPIAT

BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma Using Functional Respiratory Imaging

Urine CXCL10 Monitoring Trial in Kidney Transplant

A Phase 1, Open Label Study of Intravenous GSK3745417 to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Determine RP2D & Schedule in Participants With Relapsed or Refractory Myeloid Malignancies Including AML and HR MDS

Study to Investigate Hepatic Impairment on PK, Safety, Tolerability of Camizestrant in Post-Menopausal Female Subjects